bimatoprost Formulation C

DRUG3 trials

Sponsors

Allergan

Conditions

AlopeciaAlopecia, AndrogeneticBaldness

Phase 1

Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia

CompletedNCT01189279

AllerganAlopecia, Alopecia, Androgenetic, Baldness

Start: 2010-10-31End: 2011-02-28Updated: 2013-08-30

Phase 2

Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia

CompletedNCT01325337

AllerganAlopecia, Alopecia, Androgenetic, Baldness

Start: 2011-06-30End: 2012-09-30Updated: 2014-04-10

Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss

CompletedNCT01325350

AllerganAlopecia, Baldness

Start: 2011-06-30End: 2012-09-30Updated: 2014-04-09